Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Submitted by
admin
on December 3, 2013 - 11:04am
Source:
Seeking Alpha
News Tags:
pSivida
ophthalmology
GSK
Novartis
Pfizer
Regeneron
Roche
Sanofi
Iluvien
Durasert
Medidur
Headline:
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Do Not Allow Advertisers to Use My Personal information
